Literature DB >> 33432230

IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.

Yuying Liu1,2, Nannan Zhou1, Li Zhou1, Jing Wang3, Yabo Zhou1, Tianzhen Zhang1, Yi Fang3, Jinwei Deng4, Yunfeng Gao1, Xiaoyu Liang1, Jiadi Lv1, Zhenfeng Wang1, Jing Xie1, Yuanbo Xue5,6, Huafeng Zhang7, Jingwei Ma7, Ke Tang7, Yiliang Fang1, Feiran Cheng1, Chengjuan Zhang8,9, Bing Dong10, Yuzhou Zhao11, Peng Yuan12, Quanli Gao13, Haizeng Zhang3, F Xiao-Feng Qin14, Bo Huang15,16,17.   

Abstract

CD8+ T cell exhaustion dampens antitumor immunity. Although several transcription factors have been identified that regulate T cell exhaustion, the molecular mechanisms by which CD8+ T cells are triggered to enter an exhausted state remain unclear. Here, we show that interleukin-2 (IL-2) acts as an environmental cue to induce CD8+ T cell exhaustion within tumor microenvironments. We find that a continuously high level of IL-2 leads to the persistent activation of STAT5 in CD8+ T cells, which in turn induces strong expression of tryptophan hydroxylase 1, thus catalyzing the conversion to tryptophan to 5-hydroxytryptophan (5-HTP). 5-HTP subsequently activates AhR nuclear translocation, causing a coordinated upregulation of inhibitory receptors and downregulation of cytokine and effector-molecule production, thereby rendering T cells dysfunctional in the tumor microenvironment. This molecular pathway is not only present in mouse tumor models but is also observed in people with cancer, identifying IL-2 as a novel inducer of T cell exhaustion.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33432230     DOI: 10.1038/s41590-020-00850-9

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  47 in total

1.  Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

Authors:  Jesse M Zaretsky; Angel Garcia-Diaz; Daniel S Shin; Helena Escuin-Ordinas; Willy Hugo; Siwen Hu-Lieskovan; Davis Y Torrejon; Gabriel Abril-Rodriguez; Salemiz Sandoval; Lucas Barthly; Justin Saco; Blanca Homet Moreno; Riccardo Mezzadra; Bartosz Chmielowski; Kathleen Ruchalski; I Peter Shintaku; Phillip J Sanchez; Cristina Puig-Saus; Grace Cherry; Elizabeth Seja; Xiangju Kong; Jia Pang; Beata Berent-Maoz; Begoña Comin-Anduix; Thomas G Graeber; Paul C Tumeh; Ton N M Schumacher; Roger S Lo; Antoni Ribas
Journal:  N Engl J Med       Date:  2016-07-13       Impact factor: 91.245

Review 2.  Tumor Antigen Escape from CAR T-cell Therapy.

Authors:  Robbie G Majzner; Crystal L Mackall
Journal:  Cancer Discov       Date:  2018-08-22       Impact factor: 39.397

3.  Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing.

Authors:  Chunhong Zheng; Liangtao Zheng; Jae-Kwang Yoo; Huahu Guo; Yuanyuan Zhang; Xinyi Guo; Boxi Kang; Ruozhen Hu; Julie Y Huang; Qiming Zhang; Zhouzerui Liu; Minghui Dong; Xueda Hu; Wenjun Ouyang; Jirun Peng; Zemin Zhang
Journal:  Cell       Date:  2017-06-15       Impact factor: 41.582

4.  Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment.

Authors:  Xingzhe Ma; Enguang Bi; Yong Lu; Pan Su; Chunjian Huang; Lintao Liu; Qiang Wang; Maojie Yang; Matthew F Kalady; Jianfei Qian; Aijun Zhang; Anisha A Gupte; Dale J Hamilton; Chengyun Zheng; Qing Yi
Journal:  Cell Metab       Date:  2019-04-25       Impact factor: 27.287

5.  [New contents in Ruta graveolens L. 3. Studies in the field of the chemistry of natural substances].

Authors:  J Reisch
Journal:  Pharmazie       Date:  1965-07       Impact factor: 1.267

6.  Lineage tracking reveals dynamic relationships of T cells in colorectal cancer.

Authors:  Lei Zhang; Xin Yu; Liangtao Zheng; Yuanyuan Zhang; Yansen Li; Qiao Fang; Ranran Gao; Boxi Kang; Qiming Zhang; Julie Y Huang; Hiroyasu Konno; Xinyi Guo; Yingjiang Ye; Songyuan Gao; Shan Wang; Xueda Hu; Xianwen Ren; Zhanlong Shen; Wenjun Ouyang; Zemin Zhang
Journal:  Nature       Date:  2018-10-29       Impact factor: 49.962

7.  Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Authors:  Lukas Baitsch; Petra Baumgaertner; Estelle Devêvre; Sunil K Raghav; Amandine Legat; Leticia Barba; Sébastien Wieckowski; Hanifa Bouzourene; Bart Deplancke; Pedro Romero; Nathalie Rufer; Daniel E Speiser
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

8.  Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.

Authors:  Julien Fourcade; Zhaojun Sun; Mourad Benallaoua; Philippe Guillaume; Immanuel F Luescher; Cindy Sander; John M Kirkwood; Vijay Kuchroo; Hassane M Zarour
Journal:  J Exp Med       Date:  2010-09-06       Impact factor: 14.307

9.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

10.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

View more
  44 in total

Review 1.  Application of ATAC-seq in tumor-specific T cell exhaustion.

Authors:  Chufeng Chen; Jiaying Liu; Yidong Chen; Anqi Lin; Weiming Mou; Lingxuan Zhu; Tao Yang; Quan Cheng; Jian Zhang; Peng Luo
Journal:  Cancer Gene Ther       Date:  2022-07-06       Impact factor: 5.987

Review 2.  Activation-induced cell death in CAR-T cell therapy.

Authors:  Tian Huan; Dongfeng Chen; Guodong Liu; Hailing Zhang; Xiaoyan Wang; Zhi Wu; Yan Wu; Qinggang Xu; Feng Yu
Journal:  Hum Cell       Date:  2022-01-15       Impact factor: 4.174

Review 3.  Metabolic adaptation of lymphocytes in immunity and disease.

Authors:  Nicole M Chapman; Hongbo Chi
Journal:  Immunity       Date:  2022-01-11       Impact factor: 31.745

Review 4.  Cell-intrinsic view of the aryl hydrocarbon receptor in tumor immunity.

Authors:  Joseph W Dean; Liang Zhou
Journal:  Trends Immunol       Date:  2022-02-05       Impact factor: 16.687

Review 5.  Metabolic regulation of the cancer-immunity cycle.

Authors:  Luis F Somarribas Patterson; Santosha A Vardhana
Journal:  Trends Immunol       Date:  2021-10-02       Impact factor: 16.687

Review 6.  Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.

Authors:  Lulu Zhang; Bo Zhang; Lin Li; Yingchun Ye; Yuchuan Wu; Qing Yuan; Wenfeng Xu; Xue Wen; Xiyuan Guo; Siji Nian
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-15       Impact factor: 4.322

7.  An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery.

Authors:  Jiao Shen; Zhuangzhi Zou; Jingya Guo; Yueqi Cai; Diyuan Xue; Yong Liang; Wenyan Wang; Hua Peng; Yang-Xin Fu
Journal:  J Exp Med       Date:  2022-09-27       Impact factor: 17.579

Review 8.  Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Cell Oncol (Dordr)       Date:  2022-05-19       Impact factor: 7.051

9.  Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma.

Authors:  Zhilin Long; Chengfang Sun; Min Tang; Yin Wang; Jiayan Ma; Jichuan Yu; Jingchao Wei; Jianzhu Ma; Bohan Wang; Qi Xie; Jiaming Wen
Journal:  Cell Discov       Date:  2022-07-19       Impact factor: 38.079

Review 10.  Intratumor microbiome in cancer progression: current developments, challenges and future trends.

Authors:  Jinyan Liu; Yi Zhang
Journal:  Biomark Res       Date:  2022-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.